标题
Cost-effectiveness of precision medicine: a scoping review
作者
关键词
-
出版物
International Journal of Public Health
Volume 64, Issue 9, Pages 1261-1271
出版商
Springer Science and Business Media LLC
发表日期
2019-10-26
DOI
10.1007/s00038-019-01298-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance
- (2018) Courtney J. Balentine et al. SURGERY
- Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
- (2017) Tristan Snowsill et al. HEALTH TECHNOLOGY ASSESSMENT
- Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
- (2017) Pablo Lázaro et al. Journal of Clinical Lipidology
- Incremental cost-effectiveness of algorithm-driven genetic testing versus no testing for Maturity Onset Diabetes of the Young (MODY) in Singapore
- (2017) Hai Van Nguyen et al. JOURNAL OF MEDICAL GENETICS
- Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions
- (2017) Ching-Hua Ke et al. JOURNAL OF RHEUMATOLOGY
- A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives
- (2017) Zanfina Ademi et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype
- (2017) Laura Hörster et al. LEUKEMIA RESEARCH
- Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
- (2017) James Buchanan et al. PHARMACOECONOMICS
- Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
- (2017) M Verbelen et al. PHARMACOGENOMICS JOURNAL
- Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
- (2017) Y Wang et al. PHARMACOGENOMICS JOURNAL
- A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events
- (2017) M E Moretti et al. PHARMACOGENOMICS JOURNAL
- A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer
- (2017) Yonghong Li et al. VALUE IN HEALTH
- Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
- (2017) Louis P. Garrison et al. VALUE IN HEALTH
- Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany
- (2016) Marika Plöthner et al. ADVANCES IN THERAPY
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations
- (2016) Elvira D’Andrea et al. GENETICS IN MEDICINE
- Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age
- (2016) Anne Goverde et al. GYNECOLOGIC ONCOLOGY
- A personalized paradigm in the treatment of platinum-resistant ovarian cancer – A cost utility analysis of genomic-based versus cytotoxic therapy
- (2016) J.J. Wallbillich et al. GYNECOLOGIC ONCOLOGY
- A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions
- (2016) Catrin O. Plumpton et al. PHARMACOECONOMICS
- HLA-B*57
- (2016) Cristina Ruiz-Iruela et al. Pharmacogenetics and Genomics
- Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
- (2016) T I Verhoef et al. PHARMACOGENOMICS JOURNAL
- Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea
- (2016) Eun-A Lim et al. PLoS One
- Other side of the coin for personalised medicine and healthcare: content analysis of ‘personalised’ practices in the literature
- (2016) Tomris Cesuroglu et al. BMJ Open
- Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
- (2016) Elizabeth J. J. Berm et al. PLoS One
- Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan
- (2016) Ying-Erh Chen et al. PLoS One
- A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients
- (2015) Tristan Snowsill et al. BMC CANCER
- Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
- (2015) Dov Shiffman et al. BMC Cardiovascular Disorders
- Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
- (2015) Catrin O. Plumpton et al. EPILEPSIA
- Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis
- (2015) Carlos J. Gallego et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Effectiveness of Screening Strategies for Lynch Syndrome
- (2015) Afsaneh Barzi et al. JNCI-Journal of the National Cancer Institute
- Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer
- (2015) Yusuke Narita et al. LUNG CANCER
- Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
- (2015) Katharina Schremser et al. PHARMACOECONOMICS
- Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice
- (2015) Bruce R Schackman et al. PHARMACOGENOMICS
- Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis
- (2015) Joyce HS You PHARMACOGENOMICS
- Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
- (2015) O Alagoz et al. PHARMACOGENOMICS JOURNAL
- A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young Adults
- (2015) Fernando Matias Gonzalez et al. VALUE IN HEALTH
- Comparative Effectiveness of Screening Strategies for Lynch Syndrome
- (2015) Afsaneh Barzi et al. JNCI-Journal of the National Cancer Institute
- Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
- (2015) B. Jahn et al. SpringerPlus
- Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
- (2015) Ildar Akhmetov et al. EPMA Journal
- Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
- (2015) C. Rubio-Terrés et al. Applied Health Economics and Health Policy
- Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
- (2014) Hideko Yamauchi et al. BMC HEALTH SERVICES RESEARCH
- A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
- (2014) Tristan Snowsill et al. HEALTH TECHNOLOGY ASSESSMENT
- HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?
- (2014) Don Husereau et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
- (2014) Zanfina Ademi et al. Journal of Clinical Lipidology
- Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
- (2014) Ranjit Manchanda et al. JNCI-Journal of the National Cancer Institute
- Is Individualized Medicine More Cost-Effective? A Systematic Review
- (2014) Maximilian H. M. Hatz et al. PHARMACOECONOMICS
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing
- (2014) Wayne S. Lee et al. SURGERY
- Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand
- (2014) Huey Yi Chong et al. THROMBOSIS RESEARCH
- Economic Evaluation of Using a Genetic Test to Direct Breast Cancer Chemoprevention in White Women with a Previous Breast Biopsy
- (2014) Linda E. Green et al. Applied Health Economics and Health Policy
- Cost-Effectiveness of Pharmacogenetics-Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation
- (2013) J Pink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
- (2013) Rochelle N. Naylor et al. DIABETES CARE
- The economic value of personalized medicine tests: what we know and what we need to know
- (2013) Kathryn A Phillips et al. GENETICS IN MEDICINE
- Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2013) Joyce H.S. You Pharmacogenetics and Genomics
- Herausforderungen an die klinische Evaluation und Gesundheitsökonomie auf dem Weg zur personalisierten Medizin
- (2012) B. Brüggenjürgen et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group
- (2012) Eric Faulkner et al. VALUE IN HEALTH
- How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?
- (2011) Linda E. Coate et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature
- (2010) Stefan Vegter et al. DRUG DEVELOPMENT RESEARCH
- Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
- (2010) Rena Conti et al. MEDICAL DECISION MAKING
- Cost Effectiveness of Pharmacogenomics
- (2010) William B. Wong et al. PHARMACOECONOMICS
- Systematic review of pharmacoeconomic studies of pharmacogenomic tests
- (2010) Mathieu Beaulieu et al. PHARMACOGENOMICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Pharmacoeconomics in the Era of Individualized Medicine
- (2008) SA Waldman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis
- (2008) Scott D Grosse et al. GENETICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started